Safety Profile of Meloxicam: Analysis of Adverse Event Reports in the Czech Republic. Mlíchová J, Mészáros V, Šimandl O, Kmoníčková E, Kalátová D, Paluch Z. Journal Article 2025; 46(3): 198-202 PubMed PMID: 41066714 Citation INTRODUCTION: Meloxicam is a preferential cyclooxygenase-2 inhibitor widely prescribed for rheumatic diseases. Given its long clinical use..... Read abstract